Early Specialized Palliative Care for Unresectable Pancreatic Cancer: A Quasi-Experimental Study

Area of Science:

• Oncology
• Palliative Care
• Health Services Research

Background:

• Unresectable pancreatic cancer presents a poor prognosis and significant healthcare demands.
• Optimizing care for these patients is crucial for improving outcomes and resource utilization.

Purpose of the Study:

• To assess the impact of early specialized palliative care on hospital utilization in patients with unresectable pancreatic cancer.
• To investigate the effects of home-visit palliative care on survival and quality of life.

Main Methods:

• A quasi-experimental design compared patients receiving early specialized palliative care (n=65) with a retrospective control cohort (n=60).
• The primary endpoint was hospital care utilization, with secondary outcomes including survival, quality of life, and place of death.

Main Results:

• The intervention cohort showed significantly longer median overall survival (8.0 vs 4.9 months, P=0.029).
• Despite longer survival, the intervention group had reduced monthly hospital admissions (0.8 vs 1.2, P=0.002), emergency department visits (0.4 vs 0.6, P=0.009), and hospital days (4.2 vs 7.2, P=0.001).
• Fewer patients in the intervention cohort died in hospital outside a palliative care unit (14.5% vs 30.5%, P=0.035).

Conclusions:

• Early specialized palliative care for unresectable pancreatic cancer increases survival.
• This care model enhances patient outcomes without escalating hospital care use.
• Specialized palliative care can improve end-of-life care and reduce hospital resource burden.